HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qiang Su Selected Research

picric acid (picrate)

10/2018Role of TLR4/MyD88/NF-κB signaling pathway in coronary microembolization-induced myocardial injury prevented and treated with nicorandil.
11/2017Effects of nicorandil on PI3K/Akt signaling pathway and its anti-apoptotic mechanisms in coronary microembolization in rats.
11/2015Mechanism of programmed cell death factor 4/nuclear factor-κB signaling pathway in porcine coronary micro-embolization-induced cardiac dysfunction.
4/2010[Cardiomyocyte apoptosis and death receptor pathway in a rat model of coronary microembolization].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qiang Su Research Topics

Disease

18Neoplasms (Cancer)
10/2022 - 07/2015
13Myocardial Infarction
03/2021 - 01/2009
12Inflammation (Inflammations)
01/2021 - 11/2013
12Acute Coronary Syndrome
09/2019 - 04/2012
11Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 12/2013
8ST Elevation Myocardial Infarction
06/2022 - 06/2013
7Hypoxia (Hypoxemia)
04/2022 - 11/2017
6Infarction (Infarctions)
04/2022 - 04/2010
6Myocardial Ischemia (Ischemic Heart Diseases)
01/2022 - 09/2016
5No-Reflow Phenomenon
06/2022 - 01/2014
4Type 2 Diabetes Mellitus (MODY)
01/2022 - 12/2017
4Reperfusion Injury
01/2022 - 01/2021
4Wounds and Injuries (Trauma)
01/2021 - 01/2007
4Atherosclerosis
11/2020 - 01/2015
3Alzheimer Disease (Alzheimer's Disease)
11/2022 - 01/2018
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2022 - 08/2017
3Infections
02/2021 - 01/2007
3Heart Failure
01/2021 - 01/2018
3Pancreatitis
01/2018 - 01/2007
3Unstable Angina
12/2017 - 01/2014
3Shock
01/2009 - 01/2007
2Melanoma (Melanoma, Malignant)
08/2022 - 01/2018
2Mitochondrial Diseases (Mitochondrial Disease)
04/2022 - 03/2021
2Pain (Aches)
02/2022 - 01/2021
2Chemical and Drug Induced Liver Injury
12/2021 - 01/2021
2Diarrhea
02/2021 - 01/2018
2Prostatic Neoplasms (Prostate Cancer)
01/2021 - 05/2017
2Ischemia
01/2020 - 01/2019
2Lung Neoplasms (Lung Cancer)
01/2019 - 05/2012
2Stroke (Strokes)
01/2019 - 01/2018
2Coronary Artery Disease (Coronary Atherosclerosis)
12/2018 - 10/2018
2Coronary Disease (Coronary Heart Disease)
01/2018 - 01/2014
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2018 - 01/2018
2Renal Insufficiency (Renal Failure)
11/2017 - 03/2017
2Insulin Resistance
10/2016 - 01/2016
2Atrioventricular Block
05/2015 - 06/2013
2Hypotension (Low Blood Pressure)
05/2015 - 06/2013
2Bradycardia
05/2015 - 06/2013
2Asthma (Bronchial Asthma)
01/2014 - 11/2013
1Neoplasm Metastasis (Metastasis)
10/2022
1Brain Neoplasms (Brain Tumor)
10/2022
1Squamous Cell Carcinoma of Head and Neck
08/2022
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2022
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
08/2022

Drug/Important Bio-Agent (IBA)

8Immune Checkpoint InhibitorsIBA
08/2022 - 01/2018
8MicroRNAs (MicroRNA)IBA
01/2022 - 01/2017
7Long Noncoding RNAIBA
06/2022 - 01/2019
6Biomarkers (Surrogate Marker)IBA
10/2022 - 05/2017
6Proteins (Proteins, Gene)FDA Link
08/2022 - 01/2014
6Hematoxylin (Haematoxylon)IBA
04/2022 - 04/2010
5Eosine Yellowish-(YS) (Eosin)IBA
04/2022 - 04/2010
5Reactive Oxygen Species (Oxygen Radicals)IBA
04/2022 - 01/2020
5omega-Chloroacetophenone (Mace)IBA
01/2019 - 01/2014
4NivolumabIBA
01/2019 - 01/2018
4basic fuchsinIBA
10/2018 - 04/2010
4picric acid (picrate)IBA
10/2018 - 04/2010
3Peptides (Polypeptides)IBA
10/2022 - 01/2021
3Programmed Cell Death 1 ReceptorIBA
08/2022 - 01/2019
3TaurineFDA Link
01/2021 - 01/2019
3EnzymesIBA
01/2021 - 11/2017
3Messenger RNA (mRNA)IBA
01/2020 - 01/2014
3InterleukinsIBA
01/2019 - 07/2015
3Atorvastatin (Lipitor)FDA Link
01/2019 - 12/2013
3pembrolizumabIBA
01/2019 - 01/2018
3oxidized low density lipoproteinIBA
11/2018 - 01/2015
3Nicorandil (SG 75)IBA
10/2018 - 11/2017
3Trimetazidine (Vastarel)IBA
12/2017 - 03/2017
3Verapamil (Calan)FDA LinkGeneric
05/2015 - 06/2013
2Apoptosis Regulatory ProteinsIBA
08/2022 - 12/2021
2SincalideFDA Link
04/2022 - 01/2021
2AlbuminsIBA
01/2022 - 01/2021
2CurcuminIBA
01/2022 - 01/2021
2HydrogelsIBA
01/2022 - 01/2021
2Apolipoproteins E (ApoE)IBA
01/2022 - 01/2015
2Circular RNAIBA
12/2021 - 01/2020
2Cytochrome P-450 CYP2C19IBA
12/2021 - 09/2019
2apatinibIBA
04/2020 - 01/2018
2Angiogenesis InhibitorsIBA
04/2020 - 01/2018
2Small Interfering RNA (siRNA)IBA
01/2020 - 10/2013
2Biological ProductsIBA
01/2020 - 11/2013
2Clopidogrel (Plavix)FDA Link
09/2019 - 01/2018
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019 - 10/2018
2tetramethylpyrazineIBA
01/2019 - 11/2017
2IpilimumabIBA
01/2019 - 01/2018
2NF-kappa B (NF-kB)IBA
10/2018 - 09/2018
2Adenosine (Adenocard)FDA LinkGeneric
05/2015 - 06/2013
2interleukin-21 (interleukin 21)IBA
01/2014 - 11/2013
1Amyloid beta-PeptidesIBA
11/2022
1N-AcetylgalactosaminyltransferasesIBA
10/2022
1MucinsIBA
10/2022
1IsoenzymesIBA
10/2022
1LigandsIBA
08/2022
15-nitro-2-(3-phenylpropylamino)benzoic acidIBA
06/2022

Therapy/Procedure

21Percutaneous Coronary Intervention
06/2022 - 01/2013
15Therapeutics
11/2021 - 01/2014
9Drug Therapy (Chemotherapy)
08/2022 - 01/2018
2Aftercare (After-Treatment)
01/2022 - 02/2021
2Drug-Eluting Stents
11/2017 - 01/2014
2Cardiopulmonary Resuscitation (CPR)
10/2007 - 01/2007
1Immunotherapy
10/2022